AtriCure today announced preliminary fourth-quarter revenue results that beat the expectations of Wall Street analysts. The Mason, Ohio–based developer of surgical tools for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management expects to report Q4 2023 revenue of $106.5 million, up 21% year-over-year. The consensus on The Street was $102.43 million. […]
MassDevice Earnings Roundup
iRhythm releases strong Q4 prelims, strengthens balance sheet
iRhythm Technologies today released a solid preliminary earnings update that included projections of up to 20% revenue growth in 2024. The wearable cardiac monitors developer saw IRTC shares jump more than 7% in value to $112.91 apiece by the close of trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical […]
NeuroOne stock is down on Q4 revenue misses
NeuroOne Medical Technologies (Nasdaq:NMTC) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast. Shares of NMTC fell 8.2% at $1.58 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — dipped 0.2%. The Eden Prairie, Minnesota-based company […]
Report: There’s still ‘mutual interest’ with EOFlow, Medtronic despite deal falling through
Business Korea reports that EOFlow CEO Kim Jae-jin is leaving the door open with regard to the company’s collapsed deal with Medtronic . Medtronic announced this week that it terminated its $738 million agreement to acquire EOFlow, a maker of insulin patch pumps. The medtech giant cited “multiple breaches” of terms in the agreement as […]
Johnson & Johnson MedTech says new products will fuel growth
Johnson & Johnson considers itself “uniquely positioned to lead the next wave of healthcare innovation.” Ahead of a meeting with the investment community today, the company outlined its views on where it stands in the medtech and pharmaceutical markets. New Brunswick, New Jersey-based Johnson & Johnson set long-term financial targets, including at least 3% sales […]
Nevro acquires joint fusion device maker Vyrsa, closes credit facility and refinancing
Nevro (NYSE:NVRO) announced that it acquired Vyrsa Technologies, a company developing a minimally invasive joint pain treatment. Vyrsa has a portfolio of sacroiliac (SI) joint pain devices for use in SI joint fusion procedures. Established in 2021, the company manufactures and supports a complete portfolio of FDA-cleared devices. Dr. David Caraway, Nevro chief medical officer, […]
Medtronic’s mid-single digit revenue growth continues
Medtronic today reported second-quarter results that beat the Wall Street analysts’ consensus, with the world’s largest medtech company reporting strength across businesses and geographies. Along with a raised full-year guidance, the news sent MDT shares up more than 4% to $78.74 apiece by afternoon trading today. MassDevice‘s MedTech 100 Index was up slightly. The positive […]
Alcon stock dips on Q3 misses, tightened guidance
Alcon shares fell this morning on third-quarter results that missed the consensus forecast. Shares of ALC dipped 6.9% at $69.82 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%. The Geneva, Switzerland–based eye care device company posted profits of $204 […]
Vicarious Surgical has more layoffs, pushes back regulatory timeline for surgical robot
Vicarious Surgical (NYSE:RBOT) pushed back expectations on the timeline for its surgical robot as it trimmed its headcount for the second time this year. Shares of RBOT were down nearly 30% to 28¢ apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose […]
Senseonics posts mixed Q3, iCGM designation expected next year
Senseonics (NYSE:SENS) shares remained mostly unchanged today on third-quarter results that came in mixed compared to the consensus forecast. Shares of SENS dipped 0.3% at 51¢ apiece before the market opened today. The Germantown, Maryland-based implantable continuous glucose monitor (CGM) maker posted losses of $24.1 million. That equals 4¢ per share on sales of $6.1 […]
BD stock plummets on mixed Q4 results
BD shares took a hit this morning on fourth-quarter results that came in mixed compared to the consensus forecast. Shares of BDX fell 9.2% at $232.29 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell slightly. The Franklin Lakes, New Jersey-based company […]